Tag: peripheral artery disease market demand

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Peripheral Artery Disease Market Size from 2025 to 2034?

In the past few years, the market size for peripheral artery disease has significantly expanded. The market, which is valued at $4.31 billion in 2024, is anticipated to rise to $4.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%. The historical growth can be linked to multiple factors, chiefly the rise in risk factors prevalence, an expanding aging population, the influence of clinical research and evidence-based medicine, as well as awareness campaigns and screening programs, and government initiatives related to healthcare.

The market for peripheral artery disease is anticipated to witness considerable expansion in the forthcoming years, with projections estimating that it will reach$6.2 billion by 2029, displaying a compound annual growth rate (CAGR) of 7.6%. The reasons for this growth during the projected period include an emphasis on patient-oriented care, progress in minimally invasive treatments, the rise of digital health and remote patient monitoring, advancements in regenerative medicine, and specific drug therapies. The period is also likely to see significant trends such as initiatives for health equality, the incorporation of wearable technology, growth in home-based recovery, the importance of patient-reported outcomes (pros), and a transition towards outpatient care.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What External and Internal Drivers Are Contributing to the Growth of thePeripheral Artery Disease Market?

The increase in the incidence of peripheral artery diseases is anticipated to drive the growth of the peripheral artery disease market in the future. Peripheral artery disease is a condition characterized by the narrowing or blockage of arteries not located in the heart, typically in the legs. This can lead to a decrease in blood flow and potential complications. Treatment for peripheral artery disease aims to alleviate the symptoms, improve mobility and reduce the risk of severe complications, thereby enhancing the quality of life for patients. The American Heart Association, a US-based non-profit organization, stated in June 2023, that it’s estimated that this condition impacts anywhere from 7 to 12 million individuals in the United States and 200 million people around the globe. Hence, the increasing incidence of peripheral artery diseases is catalyzing the growth of the peripheral artery disease market.

What Segment Types Define the Peripheral Artery Disease Market Structure?

The peripheral artery diseasemarket covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons; Peripheral Stents; Peripheral Catheters; Inferior Vena Cava (IVC) Filters; Plaque Modification Devices; Hemodynamic Flow Alteration Devices; Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs; Blood Pressure Lowering Drugs; Glucose Regulating Drugs; Blood Clot Preventing Drugs; Inotropes; Thrombolytics Agents; Anti-Inflammatory Agents

3) By Route of Administration: Oral; Parenteral; Other Routes of Administration

4) By End Users: Hospitals; Specialty Clinics; Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons; Non-Drug-Eluting Balloons; Scoring Balloons; Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents; Bare Metal Stents; Covered Stents

3) By Peripheral Catheters: Sheath Introducers; Guidewires; Diagnostic Catheters; Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters; Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices; Laser Atherectomy Devices; Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices; Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories; Accessory Kits for Interventional Procedures; Support Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Peripheral Artery Disease Market?

The rise in technological innovations is a significant trend being observed in the peripheral artery disease market. Leading corporations in this sector are embracing high-tech surgical procedures to maintain their market dominance. One such example occurred in November 2022 when Genesis MedTech Group, a medical device firm based in Singapore, launched the chocolate touch paclitaxel DCB catheter. This is a percutaneous transluminal angioplasty (PTA) catheter used to treat patients suffering from superficial femoral artery and popliteal artery disease. It holds the distinction as the only balloon catheter device that pairs the delivery of therapeutic agents with a state-of-the-art angioplasty platform for treating peripheral artery disease. The device employs cushion-like structures laden with a special chemical that inflates in small sections. These provide an alternative treatment to traditional drug-coated balloon angioplasty for individuals with peripheral artery disease. Consequently, this increases the balloon’s surface area, optimizing the delivery of medication to the vascular wall and removing the necessity for permanent implants.

View the full report here:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What Is the Definition of the Peripheral Artery Disease Market?

Peripheral artery disease (PAD) is a disorder that causes the arteries that carry blood to the limbs, most commonly the legs, to thin or block. It is usually caused by atherosclerosis, characterized by the accumulation of fatty deposits (plaques) inside the artery walls, resulting in decreased blood flow to the afflicted regions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Peripheral Artery Disease Market Size Changed, over the years?

In recent times, the market size for peripheral artery disease has seen a robust expansion. A surge from $4.31 billion in 2024 to a projected $4.63 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.5%, is expected. The historic growth rate is attributed to factors such as increasing risk prevalence, the growing number of elderly individuals, clinical research & evidence-based healthcare, awareness & screening initiatives, and government healthcare policies.

How Much Will the Peripheral Artery Disease Market Be Worth in 2029?

The market size of peripheral artery disease is predicted to experience notable expansion in the upcoming years. It is projected to reach $6.23 billion by 2029, growing at a compounded annual growth rate (CAGR) of 7.7%. This growth during the forecast period is connected to efforts towards patient-centric care, advancements in minimally invasive techniques, developments in digital health and remote surveillance, the approach towards regenerative medicine, and targeted pharmaceutical treatments. Major anticipated trends during the forecast period encompass healthcare fairness initiatives, the incorporation of wearable technology, the growth of home-based rehabilitation, patient-reported outcomes (pros), and a transition to outpatient facilities.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Which is the Largest Company in the Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

What Are the Main Market Drivers in the Peripheral Artery Disease Industry?

The increased occurrence of peripheral artery disorders is projected to fuel the expansion of the peripheral artery disease market in the future. Peripheral artery disease entails the constriction or obstruction of arteries located outside the heart, often in the legs, causing decreased blood circulation and potential complications. Treatments for peripheral artery disease aim to alleviate the symptoms of the disease, improve mobility and minimize the risk of serious complications, thereby enhancing patient living conditions. For example, as per the American Heart Association in June 2023, a US-based non-profit organization, it is speculated that the disease affects between 7 to 12 million people in the United States and 200 million individuals worldwide. Thus, the growing prevalence of peripheral artery conditions is accelerating the expansion of the peripheral artery disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

How Is the Peripheral Artery Disease Market Segments Structured?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

What Strategic Trends Are Transforming the Peripheral Artery Disease Market?

One key trend that is emerging in the peripheral artery disease market is the adoption of cutting-edge technology. Major businesses in the market are utilizing advanced surgical procedures to maintain their dominance. Notably, in November 2022, Genesis MedTech Group, a medical device company based in Singapore, launched a new product called Chocolate Touch paclitaxel DCB catheter. This Percutaneous Transluminal Angioplasty (PTA) catheter serves as a treatment option for individuals with superficial femoral artery and popliteal artery disease. The innovative feature of the Chocolate Touch drug-coated balloon is its combination of a next-generation angioplasty platform with the delivery of a therapeutic agent. This device employs pillow-like structures coated with a medicinal compound to selectively open targeted areas, providing an alternate treatment solution to standard drug-coated balloon angioplasty in peripheral artery disease patients. Consequently, the balloon’s surface area is increased, enhancing the drug delivery to the vessel wall and eliminating the need for permanent implants.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Global Regions Offer the Highest Growth in the Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

This Report Delivers Insight On:

1. How big is the peripheral artery disease market, and how is it changing globally?

2. Who are the major companies in the peripheral artery disease market, and how are they performing?

3. What are the key opportunities and risks in the peripheral artery disease market right now?

4. Which products or customer segments are growing the most in the peripheral artery disease market?

5. What factors are helping or slowing down the growth of the peripheral artery disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Peripheral Artery Disease Market?

The peripheral artery disease market is poised to grow due to the increasing prevalence of peripheral artery diseases. Peripheral artery disease essentially involves the constriction or obstruction of arteries outside the heart, typically in the legs, which leads to diminished blood flow and possible complications. Treatment for peripheral artery disease helps to alleviate the symptoms, improve mobility, and decrease the likelihood of serious complications, thus enhancing the patients’ quality of life. The American Heart Association, a non-profit organization based in the U.S., estimated in June 2023 that the number of people affected by this condition ranges from 7 to 12 million in the United States and 200 million worldwide. Consequently, the escalating prevalence of peripheral artery diseases is fueling the expansion of the peripheral artery disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

#What is the Projected CAGR for the Peripheral Artery Disease Market Size from 2025 to 2034?

The market size for peripheral artery disease has experienced significant growth in the past few years. Projected growth sees the market expanding from $4.31 billion in 2024 to $4.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors contributing to the growth during the historical period include a rise in risk factors, an increasing aging population, advancements in clinical research and evidence-based medicine, awareness and screening programs, and government healthcare initiatives.

In the coming years, a robust expansion is forecasted for the peripheral artery disease market, which is expected to reach a value of $6.23 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.7%. The predicted growth during the forecast period can be attributed to factors such as the emphasis on patient-centered care, advancements in minimally invasive procedures, the impact of digital health and remote monitoring, developments in regenerative medicine, and specific drug therapies. Notable trends for the forecast period also include efforts towards health equity, the incorporation of wearable devices, the growth of home-based rehabilitation, feedback from patient-reported outcomes (pros), and a transition to outpatient settings.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

What Are the Most Significant Market Trends Transforming thePeripheral Artery Disease Market?

In the peripheral artery disease market, technological innovations are gaining traction as a significant trend. To maintain their market position, major firms in the peripheral artery disease market are embracing advanced surgical treatments. For example, Genesis MedTech Group, a medical device company based in Singapore, launched chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter in November 2022 for treating patients with superficial femoral artery and popliteal artery disease. This first-of-its-kind balloon catheter in the device merges therapeutic agent delivery with a cutting-edge angioplasty platform for treating peripheral artery disease. It utilises cushion-like structures coated with a therapeutic substance that opens in minuscule sections, offering an alternate treatment to traditional drug-coated balloon angioplasty for individuals afflicted with peripheral artery disease. Consequently, the balloon’s surface area expands, enabling more efficient drug delivery to the vessel wall and eliminating the need for permanent implants.

What Are the Top Market Players Propelling the Growth of thePeripheral Artery Disease Industry?

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Primary Segments of the Peripheral Artery Disease Market Are Driving Growth and Industry Transformations?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Peripheral Artery Disease Market?# Market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Peripheral Artery Disease Maret 2025, By The Business Research Company:

Concrete Floor Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-floor-coatings-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Concrete Admixtures Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-admixtures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the peripheral artery disease market?

The market size for peripheral artery disease has seen a robust expansion in the past few years. The market valuation is projected to rise from $4.31 billion in 2024 to $4.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be traced back to factors like the rising frequency of risk factors, increment in the aging population, clinical study and research, evidence-based medicine, awareness efforts and screening programs, as well as government-run healthcare initiatives.

What will be the peripheral artery disease market size in the future?

The market size for peripheral artery disease is predicted to experience significant growth in the upcoming years, expanding to $6.23 billion by 2029 with a compound annual growth rate (CAGR) of 7.7%. The expected growth during the forecast period is due to factors such as a focus on patient-centered care, advances in minimally invasive techniques, growth in digital health and remote patient monitoring, regenerative medicine developments, and precise drug therapies. Key trends for the forecast period entail initiatives for health equality, incorporation of fitness trackers and smartwatches, the broadening of home-centric rehabilitation, patient’s treatment outcome reports (pros), and a shift towards outpatient environments.

Get your peripheral artery disease market report here!

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What main drivers are fueling expansion in the peripheral artery disease market?

The increase in the occurrence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market. Peripheral artery disease is a condition where arteries outside the heart, typically in the legs, get narrowed or blocked, hindering blood flow and possibly leading to further complications. The treatment for peripheral artery disease helps to alleviate its symptoms, improves mobility, and minimizes the chances of severe complications, thereby enhancing the patients’ quality of life. For example, it was projected by the American Heart Association, a nonprofit organization based in the U.S., in June 2023 that about 7 to 12 million people in the United States and 200 million worldwide are afflicted by this disease. Consequently, this upsurge in peripheral artery disease prevalence is stimulating the peripheral artery disease market’s growth.

What key areas define the segmentation of the global peripheral artery disease market?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Who are the dominant players expanding their reach in the peripheral artery disease market?

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

How are evolving market trends shaping peripheral artery disease Strategies?

The trend of technological progression is increasing in prominence within the peripheral artery disease market. Mainstream corporations active within the market are embracing advanced surgical procedures to remain competitive. For example, Genesis MedTech Group, stationed in Singapore, unveiled a chocolate touch paclitaxel DCB catheter in November 2022, an innovative percutaneous transluminal angioplasty (PTA) catheter customised to treat superficial femoral artery and popliteal artery diseases. This drug-coated balloon is unique, merging the process of administering medicinal agents with a state-of-the-art angioplasty platform to address peripheral artery disease. The balloon utilises cushion-like structures filled with a therapeutic solution that gradually opens in minuscule portions, presenting an alternate form of treatment to conventional drug-coated balloon angioplasty for those grappling with peripheral artery disease. Consequently, this increases the surface area of the balloon, ensuring a more effective delivery of medication to the vessel wall and getting rid of the need for lasting implants.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

Which regions are emerging as leaders in the peripheral artery disease market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Concrete Floor Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-floor-coatings-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Concrete Admixtures Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-admixtures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Peripheral Artery Disease Market’s Growth Rate Evolve Over the Forecast Period to 2034?

The peripheral artery disease market has expanded strongly in recent years. It is anticipated to grow from $4.31 billion in 2024 to $4.63 billion in 2025, at a CAGR of 7.5%. The historical growth drivers include the increasing prevalence of risk factors, an aging population, clinical research advancements, awareness and screening programs, and government healthcare initiatives.

The peripheral artery disease market is expected to see steady growth, reaching $6.23 billion by 2029 at a CAGR of 7.7%. This growth is attributed to a shift towards patient-centric care, innovations in minimally invasive procedures, the expansion of digital health and remote monitoring, developments in regenerative medicine, and the introduction of targeted drug therapies. Key trends in the forecast period include health equity initiatives, the integration of wearable devices, the expansion of home-based rehabilitation, a focus on patient-reported outcomes (PROs), and a transition to outpatient settings.

What Combination of Drivers Is Leading to Accelerated Growth in the peripheral artery disease Market?

The growing prevalence of peripheral artery diseases is expected to fuel the growth of the peripheral artery disease market. Peripheral artery disease is the narrowing or blockage of arteries outside the heart, often in the legs, leading to reduced blood flow and possible complications. Treatment of peripheral artery disease aims to alleviate symptoms, improve mobility, and reduce complications, enhancing patients’ well-being. In June 2023, the American Heart Association estimated that between 7 and 12 million people in the U.S. and 200 million globally are affected by this condition. Therefore, the growing prevalence of peripheral artery diseases is driving the growth of the peripheral artery disease market.

Explore Comprehensive Insights Into The Global Peripheral Artery Disease Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Who Are the Influential Players Reshaping the Peripheral Artery Disease Market Landscape?

Major companies operating in the peripheral artery disease market include:

• Cardinal Health Inc._x000D_

• Vascular Solutions Inc._x000D_

• Bayer AG_x000D_

• Abbott Laboratories_x000D_

• Medtronic plc._x000D_

What New and Evolving Trends Are Having a Lasting Impact on the Peripheral Artery Disease Market?

Technological advancements are becoming increasingly important in the peripheral artery disease market. Companies are adopting new surgical treatments to strengthen their market presence. For example, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, launched the Chocolate Touch paclitaxel DCB catheter. This drug-coated balloon is the first and only PTA catheter combining a next-generation angioplasty platform with therapeutic drug delivery, aimed at treating peripheral artery disease. The balloon’s pillow-like structures ensure effective drug delivery to the vessel wall, eliminating the need for permanent implants.

Secure Your Global Peripheral Artery Disease Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

How Are Market Segments in the Peripheral Artery Disease Industry Positioned for Long-Term Growth?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Which Geographic Locations Are Critical to the Growth of the Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Peripheral Artery Disease Market?

Peripheral artery disease (PAD) is a disorder that causes the arteries that carry blood to the limbs, most commonly the legs, to thin or block. It is usually caused by atherosclerosis, characterized by the accumulation of fatty deposits (plaques) inside the artery walls, resulting in decreased blood flow to the afflicted regions.

Browse Through More Similar Reports By The Business Research Company:

Concrete Floor Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-floor-coatings-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Concrete Admixtures Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/concrete-admixtures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: